Candesartan in Peripheral Neuropathy

Summary

Candesartan in Peripheral Neuropathy is a clinical trial^[1].

Key Facts

• Candesartan in Peripheral Neuropathy is in the country of France^[2].
• Candesartan in Peripheral Neuropathy's instance of is recorded as clinical trial^[3].
• Candesartan in Peripheral Neuropathy's start time is recorded as +2019-02-01T00:00:00Z^[4].
• Candesartan in Peripheral Neuropathy's end time is recorded as +2020-09-01T00:00:00Z^[5].
• Candesartan in Peripheral Neuropathy's number of participants is recorded as {'unit': '1', 'amount': '+40'}^[6].
• Candesartan in Peripheral Neuropathy's title is recorded as Pilot Study, Single-blind, Candesartan Versus Usual Care of Peripheral Neuropathy Development Induced by Vincristine (PNIV) in Patients Treated for Lymphoma B^[7].
• Candesartan in Peripheral Neuropathy's short name is recorded as NEUPERSART^[8].
• Candesartan in Peripheral Neuropathy's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[9].
• Candesartan in Peripheral Neuropathy's ClinicalTrials.gov ID is recorded as NCT03688633^[10].
• Candesartan in Peripheral Neuropathy's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+80'}^[11].
• Candesartan in Peripheral Neuropathy's research intervention is recorded as candesartan^[12].
• Candesartan in Peripheral Neuropathy's research intervention is recorded as candesartan cilexetil^[13].
• Candesartan in Peripheral Neuropathy's clinical trial phase is recorded as phase II clinical trial^[14].
• Candesartan in Peripheral Neuropathy's research site is recorded as CHU of Limoges^[15].
• Candesartan in Peripheral Neuropathy's research subject recruitment status is recorded as recruiting^[16].
• Candesartan in Peripheral Neuropathy's study type is recorded as interventional study^[17].